Fingerprint
Dive into the research topics of 'CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically